2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Suneel Kamath, MD, discusses the importance of including underrepresented patient populations in clinical trials.
Suneel Kamath, MD, assistant professor of Medicine, the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, discusses the importance of including underrepresented patient populations in clinical trials.
Including underrepresented groups in clinical trials helps those patients become voices for their communities at large by advocating for additional participation, Kamath says. Patients from underserved communities who do enroll in clinical trials benefit the most, and they can serve as examples of how clinical trials can provide necessary treatment, Kamath explains.
Clinical trials are a beneficial avenue for patients to voice their opinions, receive beneficial treatment, and help advocate for more inclusion, Kamath concludes.